JG
SPPI

Jefferies Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Jefferies Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-50,000
Closed -$182K – 2802
2019
Q4 		$182K Buy
+50,000
New +$404K ﹤0.01% 2282

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group's SPPI Position: Q1 2020 in Review

Jefferies Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 50,000 shares — an estimated $182K sold.

Jefferies Group first reported a position in SPPI in Q3 2018 and held it in 4 quarters. The position peaked at $223K in Q3 2018. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

  • Jefferies Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 50,000 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $182K.
  • Jefferies Group first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 4 quarters.
  • Jefferies Group's Spectrum Pharmaceuticals Inc position peaked at $223K in Q3 2018.
  • 156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.